Global Measles, Mumps, and Rubella Vaccines Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Measles, Mumps, and Rubella Vaccines Market Overview

1.1 Measles, Mumps, and Rubella Vaccines Definition

1.2 Global Measles, Mumps, and Rubella Vaccines Market Size Status and Outlook (2019-2032)

1.3 Global Measles, Mumps, and Rubella Vaccines Market Size Comparison by Region (2019-2032)

1.4 Global Measles, Mumps, and Rubella Vaccines Market Size Comparison by Type (2019-2032)

1.5 Global Measles, Mumps, and Rubella Vaccines Market Size Comparison by Application (2019-2032)

1.6 Global Measles, Mumps, and Rubella Vaccines Market Size Comparison by Sales Channel (2019-2032)

1.7 Measles, Mumps, and Rubella Vaccines Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Measles, Mumps, and Rubella Vaccines Market Snapshot

2.2 Global Measles, Mumps, and Rubella Vaccines Market Volume & Revenue (2019-2025)

2.3 Global Measles, Mumps, and Rubella Vaccines Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Measles, Mumps, and Rubella Vaccines Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Measles, Mumps, and Rubella Vaccines Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Measles, Mumps, and Rubella Vaccines Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Measles, Mumps, and Rubella Vaccines Market Segment Analysis by Player

3.1 Global Measles, Mumps, and Rubella Vaccines Sales and Market Share by Player (2023-2025)

3.2 Global Measles, Mumps, and Rubella Vaccines Revenue and Market Share by Player (2023-2025)

3.3 Global Measles, Mumps, and Rubella Vaccines Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Measles, Mumps, and Rubella Vaccines Market Segment Analysis by Type

4.1 Global Measles, Mumps, and Rubella Vaccines Market by Type

4.1.1 Monovalent Vaccine

4.1.2 Polyvalent Vaccine

4.2 Global Measles, Mumps, and Rubella Vaccines Sales and Market Share by Type (2019-2025)

4.3 Global Measles, Mumps, and Rubella Vaccines Revenue and Market Share by Type (2019-2025)

4.4 Global Measles, Mumps, and Rubella Vaccines Average Price by Type (2019-2025)

4.5 Leading Players of Measles, Mumps, and Rubella Vaccines by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Measles, Mumps, and Rubella Vaccines Market Segment Analysis by Application

5.1 Global Measles, Mumps, and Rubella Vaccines Market by Application

5.1.1 Children

5.1.2 Adults

5.2 Global Measles, Mumps, and Rubella Vaccines Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Measles, Mumps, and Rubella Vaccines by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Measles, Mumps, and Rubella Vaccines Market Segment Analysis by Sales Channel

6.1 Global Measles, Mumps, and Rubella Vaccines Market by Sales Channel

6.1.1 Global Measles, Mumps, and Rubella Vaccines Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Measles, Mumps, and Rubella Vaccines Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Measles, Mumps, and Rubella Vaccines Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Measles, Mumps, and Rubella Vaccines by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Measles, Mumps, and Rubella Vaccines Market Segment Analysis by Region

7.1 Global Measles, Mumps, and Rubella Vaccines Market Size and CAGR by Region (2019-2032)

7.2 Global Measles, Mumps, and Rubella Vaccines Sales and Market Share by Region (2019-2025)

7.3 Global Measles, Mumps, and Rubella Vaccines Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Measles, Mumps, and Rubella Vaccines Market Share by Type

7.4.3 North America Measles, Mumps, and Rubella Vaccines Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Measles, Mumps, and Rubella Vaccines Market Share by Type

7.5.3 Europe Measles, Mumps, and Rubella Vaccines Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Measles, Mumps, and Rubella Vaccines Market Share by Type

7.6.3 Asia-Pacific Measles, Mumps, and Rubella Vaccines Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Measles, Mumps, and Rubella Vaccines Market Share by Type

7.7.3 South America Measles, Mumps, and Rubella Vaccines Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Measles, Mumps, and Rubella Vaccines Market Share by Type

7.8.3 Middle East & Africa Measles, Mumps, and Rubella Vaccines Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Measles, Mumps, and Rubella Vaccines Players

8.1 Merck

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Sanofi

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 GlaxoSmithKline

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Pfizer

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 CSL

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Serum

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Bavarian Nordic

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Astellas Pharma

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Emergent BioSolutions

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Sinopharm

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 Others

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Measles, Mumps, and Rubella Vaccines

9.1 Industrial Chain of Measles, Mumps, and Rubella Vaccines

9.2 Upstream of Measles, Mumps, and Rubella Vaccines

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Measles, Mumps, and Rubella Vaccines

9.3.1 Leading Distributors/Dealers of Measles, Mumps, and Rubella Vaccines

9.3.2 Leading Consumers of Measles, Mumps, and Rubella Vaccines

Chapter 10. Global Measles, Mumps, and Rubella Vaccines Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Measles, Mumps, and Rubella Vaccines Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Measles, Mumps, and Rubella Vaccines Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Measles, Mumps, and Rubella Vaccines (2026-2032)

11.1 Global Measles, Mumps, and Rubella Vaccines Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Measles, Mumps, and Rubella Vaccines Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Measles, Mumps, and Rubella Vaccines Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Measles, Mumps, and Rubella Vaccines Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Measles, Mumps, and Rubella Vaccines Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Measles, Mumps, and Rubella Vaccines Import-Export (2019-2025)

12.2 Europe Measles, Mumps, and Rubella Vaccines Import-Export (2019-2025)

12.3 Asia Pacific Measles, Mumps, and Rubella Vaccines Import-Export (2019-2025)

12.4 South America Measles, Mumps, and Rubella Vaccines Import-Export (2019-2025)

12.5 Middle East & Africa Measles, Mumps, and Rubella Vaccines Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Measles, Mumps, and Rubella Vaccines Demand-Supply (2019-2025)

13.2 Europe Measles, Mumps, and Rubella Vaccines Demand-Supply (2019-2025)

13.3 Asia Pacific Measles, Mumps, and Rubella Vaccines Demand-Supply (2019-2025)

13.4 South America Measles, Mumps, and Rubella Vaccines Demand-Supply (2019-2025)

13.5 Middle East & Africa Measles, Mumps, and Rubella Vaccines Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources